Early lung cancer almost always causes no symptoms. It is found on a lung health check, on a scan done for something else, or on a private health scan, as a spot, a shadow or a nodule. Most of these findings are not cancer. When one is, and it is found at this stage, it is usually treated with one keyhole operation. This page explains each test, each result and each decision in the order they happen. Dr Lawrence Okiror sees new patients within 2–3 days.
Last reviewed: November 2026 · Dr Lawrence Okiror FRCS(CTh) FRCSEd(CTh) · GMC 6150382
A small growth in the lung can sit there for a long time without causing a cough, pain or breathlessness. This is why early lung cancer is almost always found by a scan and not by a symptom. People describe it as “found incidentally” or “found on a screening exam while having no symptoms”. There are three usual routes.
The NHS lung cancer screening programme has been very successful. More than 12,000 lung cancers have been diagnosed through it, and over three quarters of the cancers it finds are at an early stage. If your lung health check has found a nodule, the lung health check results page explains what each result means. If you fall outside the programme, because of your age or because you have never smoked, the screening gap page explains how a scan is arranged privately.
This is the most common route. A scan for tummy discomfort includes the lower parts of the lungs and picks up an abnormality there. A heart scan shows a nodule beside the heart. A fall or an injury to the shoulder leads to an X-ray, and the X-ray shows a shadow at the top of the lung. None of these scans was looking for it. The shadow on the lung page explains what the report means and how often these findings turn out to be nothing.
Whole-body MRI and CT scans, and blood tests that look for cancer signals, report findings in the chest more and more often. The private scan findings page explains what each kind of scan can and cannot tell you, and there is a separate page for a positive cancer blood test with a normal scan.
The three words describe the same thing: a small area in the lung that looks different from the lung around it. Doctors call it a nodule when it is under 3 cm. A nodule is a description of what the scan shows. It is not a diagnosis. Most are old infection, scar tissue or a harmless growth. Some are solid and some are hazy, and hazy ones are called ground-glass nodules. What is a lung nodule? covers this in full, and there is a page for people with several ground-glass nodules.
Dr Okiror looks at the scan images himself and uses a scoring tool called the Brock score. It takes the size of the nodule, its shape, whether it is solid or hazy, where it sits in the lung, your age, your smoking history and any family history, and gives a percentage chance that the nodule is a cancer. A low score usually means a repeat scan to confirm that nothing changes. A higher score means more tests.
A PET scan is added for nodules over 8 mm that are still uncertain after the CT. It shows how active the nodule is, and whether anything else in the body is active. The result is then put into a second score, called the Herder score, which works the risk out again with the PET result included. A nodule can move up or down after PET, and the plan changes with it. A PET result is a pointer. A diagnosis needs a sample.
It can be. A repeat CT after three months is a recognised plan for a nodule in the middle range of risk. It shows whether the nodule grows, shrinks or stays the same, and many nodules that stay the same are harmless. The waiting is hard, and people say so: “the waiting is truly the worst”.
For a nodule of 10 mm or more, a nodule that has already grown, or a wait you cannot live with, there are things that can be done sooner. The scan can be reviewed and scored again. A PET scan can be added. A sample can be taken by ION bronchoscopy as a day case. Dr Okiror reviews your images before the appointment and tells you which of these applies to your nodule, or whether the repeat scan is the right plan. The lung nodule clinic page explains how the assessment is arranged.
Most nodules are now sampled through the airways with ION robotic navigational bronchoscopy. A thin robotic tube is passed through the mouth and steered along the airways to the nodule while you are asleep. There is no cut. In South East London this is now the most common way these nodules are diagnosed. About 4 in 10 biopsies are done this way, more than CT-guided needle biopsy, frozen section at an operation or standard bronchoscopy.
It is more accurate, and it carries less risk of a collapsed lung, which happens in around 2% of cases and is nearly always minor. It is a day case. A scan taken in the room confirms the needle is in the nodule before the sample is taken, and a pathologist examines the tissue in the room, so most patients have a preliminary report on the day of the procedure. The ION bronchoscopy page describes the day in full.
A CT-guided needle biopsy suits a nodule that lies next to the chest wall with no airway running near it. The needle passes through the skin under local anaesthetic. Its main risk is a collapsed lung. Where no tube or needle can reach a nodule safely, it can be removed by a small keyhole operation, which gives the diagnosis and treats it together. That is covered on the surgical lung biopsy page.
The report names the type of cancer. The most common early type is adenocarcinoma. It may also give a grade, in words such as “well differentiated” or “poorly differentiated”. Grade describes how different the cancer cells look from normal lung cells under the microscope. It is separate from stage, which describes how far the cancer has travelled. A report may also say whether there was enough tissue for further tests on the tumour. Enough tissue for those tests is taken at the first biopsy wherever possible, so that a second procedure is not needed.
It means stage 1: a tumour of 4 cm or less that has not reached the lymph glands or anywhere else. To confirm it, the staging tests look at the rest of the body. They usually include a PET-CT, an MRI of the brain, and sampling of the lymph glands in the centre of the chest where there is any concern about them. The brain is scanned because lung cancer can be present there without symptoms, and finding that before an operation changes the plan. Tests and staging explains each test, and chest imaging explained covers what each scan shows.
Each lung is made of lobes, and each lobe is made of segments. For a small early cancer of 2 cm or less in a suitable position, the operation is usually a segmentectomy, which removes the segment holding the tumour and its lymph glands and leaves the rest of the lobe. For a larger or more central tumour the operation is a lobectomy, which removes the lobe. A wedge is a small piece of lung removed without following the segments. It is used to make a diagnosis, and for some patients who would not manage a larger operation. The choice is explained on the lung cancer surgery page.
No. More than 80% of Dr Okiror’s lung operations are keyhole operations, done through small cuts between the ribs with a camera. The ribs are not broken and are not spread apart. Most early lung cancer operations are done with the surgical robot, which Dr Okiror controls from a console in the theatre. Some are done by VATS, where he holds the keyhole instruments directly. Both are keyhole surgery.
For some fit patients with a small nodule in the outer lung, yes. The ION biopsy is done first. If the pathologist in the theatre finds cancer, the keyhole operation follows under the same anaesthetic. If the result is benign, you wake up without having had an operation. The combined biopsy and surgery page explains who this suits.
Both are treatments for stage 1 lung cancer. Surgery is the gold standard treatment, with the best long-term outcome, and it is the only one that removes the tumour and the nearby lymph glands so that both can be examined under the microscope. Focused radiotherapy, called SABR or SBRT, is given in a few outpatient sessions. For some patients, including some older patients and some whose lungs or heart would not manage an operation, it is the better choice. The decision is made with you after the lung cancer team has discussed your case.
Three worries lead people towards radiotherapy, and each is worth raising at the first appointment. The first is losing part of a lung when breathing is already limited. Your breathing is measured before any operation is offered, and a segmentectomy is designed to keep as much lung as possible. The fitness for surgery page explains the tests. The second is managing afterwards, especially if you live alone. Most patients are walking the day after the operation and go home in 2 to 4 days. The third is the wait to see a surgeon. New patients are seen within 2–3 days. Age alone does not decide it either: see lung cancer surgery in older patients.
New patients are seen within 2–3 days, and by video within 24 hours. Surgery is usually within a week of completing the tests. Patients who already have their tests can be booked for surgery within days of their consultation. Urgent cases can be booked for surgery within 48 hours. Dr Okiror reviews the scan, takes the biopsy, does the operation and sees you afterwards. Seeing a private thoracic surgeon in London sets out how to be seen, and admission and your stay covers the day itself.
Most patients go home 2 to 4 days after keyhole lung surgery. A chest drain is placed at the end of the operation to let air and fluid out while the lung settles. It is a small portable drain that you carry, so you can walk around the ward from the first day. It is almost always removed before you go home. The thoracic specialist nurses phone you in the first few days at home, and you are seen in clinic at 2 to 4 weeks.
Pain is controlled with local anaesthetic placed by the surgeon during the operation and with tablets afterwards. An area of numbness on the chest wall is common after the operation. Desk work is often possible at 2 to 4 weeks. Driving and flying are typically possible at 2 to 3 weeks and are confirmed for each patient. Physical work takes six to eight weeks or longer. The recovery page gives the timetable activity by activity, and the pain relief page explains how pain is managed.
The tumour and the lymph glands go to the laboratory. The first report gives the final stage and says whether the edges of the removed lung are clear and whether any gland is involved. People know this result as “clear margins and no lymph node involved”. The tumour is also tested for changes in its genes, such as EGFR and ALK, and for a protein called PD-L1. These results take longer, usually around two weeks. They show whether further treatment after the operation, such as a tablet treatment or immunotherapy, should be considered. Gene changes of this kind are found more often in people who have never smoked: see lung cancer in never-smokers.
For most people with stage 1 lung cancer the operation is the whole treatment. Five-year survival at stage 1 is around 80–90%. No one can promise that a cancer will not return, so you are followed with regular CT scans, and the schedule is set out at your clinic review. A brain MRI is usually part of the tests before the operation. Whether it is repeated later depends on the final laboratory report and on any symptoms, and it is decided at follow-up.
The days before each follow-up scan are an anxious time for many people. If something is found on a later scan, it is assessed in the same way as the first finding, and a further operation is sometimes possible. See lung cancer returning after surgery and a new lung cancer years later.
A new consultation is £250–£350, in person or by video, and includes Dr Okiror’s review of your scan. ION robotic bronchoscopy is £9,500–£10,500. A robotic segmentectomy or lobectomy is £25,000–£30,000. Each is an all-inclusive guide price covering the hospital, surgeon and anaesthetist fees for an uncomplicated stay. Hospital charges are the largest part of every total, and the hospital issues a written fixed quote after the consultation and before treatment. All guide prices and how fees work →
Dr Okiror is recognised by AXA Health, Bupa, Aviva, Vitality, WPA and Cigna, and by most other UK and international insurers. If you have private medical insurance, insurers usually settle the hospital, surgeon and anaesthetist fees in full, less any excess written into your policy. Self-paying patients are equally welcome.
Yes. Many patients come with a diagnosis and a plan already made, and with the operation due to take place at home. They ask whether the current investigations are sufficient, whether the proposed timing of surgery is appropriate, what would be removed, and whether a smaller operation could safely preserve more lung. Dr Okiror reviews the scans and the reports himself and answers each question. You receive a written opinion, and you can take it back to your own team. See the lung cancer second opinion page.
Your scans are sent ahead and reviewed, and the first consultation is by video. If a biopsy or an operation is needed, the tests and the treatment are planned into one trip. The patients from outside the UK page explains the arrangements.
The questions patients and their families ask between the scan and the operation.
Send Your Scan for Review →Or call Jo Mitchelson:
020 7952 2882
Appointments within 2–3 days, by video within 24 hours. Dr Okiror reviews your scan before the appointment. Self-referrals welcome. London Bridge Hospital, The Lister Hospital Chelsea, Canary Wharf and the City of London.
Jo Mitchelson, PA · 020 7952 2882 · pa@lungsurgeon.co.uk
St Thomas’ Hospital #1 UK · Guy’s Hospital #2 UK · London Bridge Hospital #10 UK · Newsweek World’s Best Hospitals 2026
Related Pages
For doctors and imaging clinics